TCGX Acquisition TCGX

TCGX Acquisition Acquisition Corp. announces SPAC deal

Merger communication

Form
425
Filed
Importance
Routine
  1. Deal values TriGemX at $600 million
  2. TriGemX gets $246 million in cash
  3. Phase 3 trial for migraine treatment underway
  4. SPAC deal set to close in Q1 2027

Written from the 425 on EDGAR. Check the filing before you rely on it.

Get an email when TCGX Acquisition files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 6770 and related industry codes: the same peer list as the financial tables.